PTJ
EW icon

Paul Tudor Jones’s Edwards Lifesciences EW Stock Holding History

Paul Tudor Jones’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
+30,800
New +$2.58M ﹤0.01% 1709
2026
Q1 		– Sell
-13,300
Closed -$1.13M – 3809
2025
Q4 		$1.13M Sell
13,300
-18,300
-58% -$1.5M ﹤0.01% 2179
2025
Q3 		$2.46M Buy
31,600
+11,800
+60% +$922K ﹤0.01% 1667
2025
Q2 		$1.55M Buy
+19,800
New +$1.48M ﹤0.01% 1841
2024
Q3 		– Sell
-2,900
Closed -$268K – 2815
2024
Q2 		$268K Buy
+2,900
New +$257K ﹤0.01% 2052
2024
Q1 		– Sell
-6,100
Closed -$465K – 2369
2023
Q4 		$465K Buy
+6,100
New +$424K ﹤0.01% 1831
2023
Q3 		– Sell
-7,200
Closed -$679K – 2446
2023
Q2 		$679K Buy
7,200
+4,200
+140% +$365K 0.01% 1540
2023
Q1 		$248K Sell
3,000
-15,600
-84% -$1.23M ﹤0.01% 2057
2022
Q4 		$1.39M Buy
18,600
+5,800
+45% +$447K 0.03% 865
2022
Q3 		$1.06M Buy
12,800
+7,000
+121% +$674K 0.02% 871
2022
Q2 		$554K Buy
5,800
+1,300
+29% +$135K 0.01% 1223
2022
Q1 		$529K Buy
+4,500
New +$505K 0.01% 1240

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Paul Tudor Jones's EW Position: Q2 2025 in Review

Paul Tudor Jones sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 115,014 shares — an estimated $8.58M sold.

Paul Tudor Jones first reported a position in EW in Q3 2013 and held it in 30 quarters. The position peaked at $19.6M in Q1 2017. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Paul Tudor Jones reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 115,014 Edwards Lifesciences shares in Q2 2025, an estimated $8.58M.
  • Paul Tudor Jones first reported a position in Edwards Lifesciences in Q3 2013 and held it in 30 quarters.
  • Paul Tudor Jones's Edwards Lifesciences position peaked at $19.6M in Q1 2017.
  • 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.